2025 Cannabinoids Epilepsy Extraction 
Veriheal
JANUARY 18, 2023
In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. Confusion surrounding British CBD laws has thrust the cannabinoid into a legal gray area.
Cannabis Law Report
JULY 26, 2019
Cannabis , better expressed as a cannabinoid drug by The Alcohol and Drug Foundation, is the product of the sativa plant which has psychoactive cannabinoid THC and non-psychoactive cannabidiol. The Australian cannabis market is expected to have a net worth of approximately $55 million by the end of 2025.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 23, 2021
This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. C3 Cannabinoid Compound Company. billion by 2025. billion by 2025. However, no single cannabinoid drug has received widespread approval in the treatment of pain.
Cannabis Law Report
JUNE 8, 2021
Cannabidiol or CBD is a natural cannabinoid that actively affects the human body. If earlier cannabis was a taboo subject due to its psychedelic properties, then with the development of technologies that allow the extraction of pure cannabidiol, the situation has changed radically. Moreover, the effect is curative. In 2018, the U.S.
Cannabis Law Report
OCTOBER 17, 2019
Plants with higher THC levels are typically bred and consumed for medical or adult recreational purposes, either in dried form for smoking or with the THC content extracted and infused into foods, beverages, topical ointments, candles, and other products. THC is just one of the cannabinoids in the Cannabis sativa L.
Expert insights. Personalized for you.
94 
Let's personalize your content